XML 43 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value
12 Months Ended
Dec. 31, 2018
Fair Value Disclosures [Abstract]  
Fair Value
Fair Value
Recurring Fair Values
The table below presents a summary of financial assets and financial liabilities carried at fair value on a recurring basis, including financial instruments for which the fair value option was elected but excluding financial assets under the NAV practical expedient.
 
 
Fair Value Measurements
(In thousands)
 
Level 1
 
Level 2
 
Level 3
 
Total
December 31, 2018
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
Equity method investments
 
$

 
$

 
$
81,085

 
$
81,085

Equity securities of consolidated funds
 
26,754

 

 

 
26,754

Debt securities available for saleN-Star CDO bonds
 

 

 
64,127

 
64,127

CMBS of consolidated fund
 

 
32,706

 

 
32,706

Other assets—derivative assets
 

 
33,558

 

 
33,558

Liabilities
 
 
 
 
 
 
 
 
Other liabilitiesderivative liabilities
 

 
132,808

 

 
132,808

Other liabilities—contingent consideration for THL Hotel Portfolio
 

 

 
8,903

 
8,903

 
 
Fair Value Measurements
(In thousands)
 
Level 1
 
Level 2
 
Level 3
 
Total
December 31, 2017
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
Loans receivable—securitized loans
 
$

 
$

 
$
45,423

 
$
45,423

Equity method investments
 

 

 
363,901

 
363,901

Equity securities of consolidated fund
 
35,600

 

 

 
35,600

Debt securities available for sale
 
 
 
 
 
 
 
 
CRE securities of consolidated N-Star CDOs:
 
 
 
 
 
 
 
 
CMBS
 

 

 
147,945

 
147,945

Other securities
 

 

 
66,983

 
66,983

N-Star CDO bonds
 

 

 
90,933

 
90,933

CMBS and other securities
 

 

 
17,382

 
17,382

CMBS of consolidated fund
 

 
25,099

 

 
25,099

Other assets—derivative assets
 

 
10,152

 

 
10,152

Liabilities
 
 
 
 
 
 
 
 
Debt—securitization bonds payable
 

 

 
44,542

 
44,542

Other liabilitiesderivative liabilities
 

 
204,848

 

 
204,848

Other liabilities—contingent consideration for THL Hotel Portfolio
 

 

 
7,419

 
7,419

Due to affiliates—contingent consideration for Internalization
 

 

 
20,650

 
20,650


Equity Method Investments
Equity method investments for which fair value option was elected are carried at fair value on a recurring basis. This includes investments in private equity funds acquired in connection with the Merger.
Fair values are determined using either discounted cash flow models based on expected future cash flows for income and realization events of the underlying assets, applying revenue multiples, based on transaction price for recently acquired investments, or pending or comparable market sales price on an investment, as applicable. In valuing the Company's investment in third party private equity funds, the Company considers cash flows provided by the general partners of the funds and the implied yields of the funds. The Company has not elected the practical expedient to measure the fair value of its investments in these private equity funds using NAV of the underlying funds. Fair value of equity method investments are classified as Level 3 of the fair value hierarchy, unless investments are valued based on contracted sales prices which are classified as Level 2 of the fair value hierarchy. Changes in fair value of equity method investments under the fair value option are recorded in equity method earnings.
Equity Securities
Fair value of equity securities held by consolidated funds are based on listed prices in active markets and classified as Level 1 of the fair value hierarchy.
Debt Securities
N-Star CDO bonds—Fair value of N-Star CDO bonds are determined internally based on recent trades, if any with such securitizations, the Company's knowledge of the underlying collateral and are determined using an internal price interpolated based on third party prices of the senior N-Star CDO bonds of the respective CDOs. All N-Star CDO bonds are classified as Level 3 of the fair value hierarchy.
CMBS and other securities—Fair value is determined based on broker quotes, third party pricing services or an internal price, all of which are generally derived from unobservable inputs, and therefore classified as Level 3 of the fair value hierarchy. Management determines the prices are representative of fair value through a review of available data, including recent transactions as well as its knowledge of and experience in the market.
Derivatives
Derivative instruments consist of interest rate contracts and foreign exchange contracts that are generally traded over-the-counter, and are valued using a third-party service provider, except for exchange traded futures contracts which are Level 1 fair values. Quotations on over-the-counter derivatives are not adjusted and are generally valued using observable inputs such as contractual cash flows, yield curve, foreign currency rates and credit spreads, and are classified as Level 2 of the fair value hierarchy. Although credit valuation adjustments, such as the risk of default, rely on Level 3 inputs, these inputs are not significant to the overall valuation of its derivatives. As a result, derivative valuations in their entirety are classified as Level 2 of the fair value hierarchy.
Due To AffiliatesContingent Consideration for Internalization
In connection with the Company's acquisition of the investment management business and operations of its former
manager in April 2015 (the "Internalization"), contingent consideration is payable to certain senior management personnel of the Company. The contingent consideration is payable in a combination of up to approximately 1.29 million shares of class A common stock, 115,226 shares of class B common stock and 4.40 million OP Units, measured based on multi-year performance targets for achievement of a contractually-defined funds from operations ("Benchmark FFO") per share target, as well as real estate and non-real estate capital-raising thresholds from the funds management business, to the extent these targets are met. If the minimum performance target for either of these metrics is not met or exceeded, a portion of the contingent consideration paid in respect of the other metric would not be paid out in full.
At December 31, 2017, the contingent consideration had been remeasured at fair value using a third party valuation service provider and classified as Level 3 of the fair value hierarchy, with the change in fair value recorded in other gain (loss) in the consolidated statement of operations. Fair value of the contingent consideration was measured using a Monte Carlo probability simulation model for the Benchmark FFO component and a discounted payout analysis based on probabilities of achieving prescribed targets for the capital-raising component, adjusted for certain targets that had not been met and that had expired. The Company's class A common stock price and related equity volatilities were applied to convert the contingent consideration payout into shares.
At June 30, 2018, the end of the measurement period for the contingent consideration, and in accordance with the terms of the contribution agreement for the Internalization, it was determined that one of the prescribed performance targets was met, specifically the real estate capital raising target. As a result, the contingent consideration was settled with certain senior management personnel of the Company in a combination of approximately 15,000 shares of class A common stock, 40,000 shares of class B common stock and 1.95 million OP Units. At June 30, 2018, as the contingency was resolved and the number of shares and units to be issued was no longer variable, the payable of $12.5 million, valued based on the closing price of the Company's class A common stock on June 29, 2018, the last trading day of the second quarter, was reclassified out of liabilities into equity, while the associated dividends payable of approximately $6.4 million remained in liabilities. The contingent consideration and associated dividends were fully settled in August 2018.
Other LiabilitiesContingent Consideration for THL Hotel Portfolio
In connection with a consensual foreclosure of the THL Hotel Portfolio, contingent consideration is payable to the former preferred equity holder of the borrower in an amount up to $13.0 million (Note 3). Fair value of the contingent consideration is measured using discounted cash flows based on the probability of the former preferred equity holder receiving such payment.
Securitized Loans and Securitized Bonds Payable
The Company had elected the fair value option for loans receivable and bonds payable issued by a securitization trust that was consolidated by a N-Star CDO. The N-Star CDO was in turn consolidated by the Company. In May 2018, the Company sold its interests in the N-Star CDO and deconsolidated the N-Star CDO (Note 8) along with the securitization trust consolidated by the N-Star CDO.
Prior to deconsolidation, the Company had adopted the measurement alternative to measure the fair value of the loans receivable held by the securitization trust using the fair value of the bonds payable issued by the securitization trust as the latter represented the more observable fair value. As such, the net gain or loss that was reflected in earnings was limited to changes in fair value of the beneficial interest held by the Company in the previously consolidated securitization trust, and not as a result of a remeasurement of the loans receivable and bonds payable held by third parties in the previously consolidated securitization trust. Fair value of the bonds payable issued by the securitization trust was determined based on broker quotes, which were generally derived from unobservable inputs, and therefore classified as Level 3 of the fair value hierarchy. Correspondingly, the fair value of the loans receivable held by the securitization trust was also classified as Level 3. Management determined that the quotes were representative of fair value through a review of available data, including recent transactions as well as its knowledge of and experience in the market.
Level 3 Recurring Fair Value Measurements
The Company relies on the third party pricing exception with respect to the requirement to provide quantitative disclosures about significant Level 3 inputs being used to determine fair value measurements for CRE debt securities, except for N-Star CDO bonds, and prior to May 2018, loans receivable and bonds payable issued by a consolidated securitization trust held by a previously consolidated N-Star CDO. The Company believes that the pricing service or broker quotations for these instruments may be based on market transactions of comparable securities, inputs including forecasted market rates, contractual terms, observable discount rates for similar securities and credit, such as credit support and delinquency rates.
Quantitative information about recurring Level 3 fair value measurements, for which information about unobservable inputs is reasonably available to the Company, are as follows.
 
 
 
 
Valuation Technique
 
Key Unobservable Inputs
 
Input Value
 
Effect on Fair Value from Increase in Input Value (1)
Financial Instrument 
 
Fair Value
(In thousands)
 
 
 
Weighted Average
(Range)
 
December 31, 2018
 
 
 
 
 
 
 
 
 
 
Level 3 Assets
 
 
 
 
 
 
 
 
 
 
Equity method investments—third party private equity funds
 
$
5,908

 
Transaction price and NAV(2)
 
Not applicable
 
Not applicable
 
Not applicable
Equity method investments—other
 
21,831

 
Discounted cash flows
 
Discount rate
 
17.5%
(9.1% - 18.4%)
 
Decrease
Equity method investments—other

 
25,000

 
Multiple
 
Revenue multiple
 
5.8x
 
Increase
Equity method investments—other

 
28,346

 
Transaction price(3)
 
Not applicable
 
Not applicable
 
Not applicable
N-Star CDO bonds
 
64,127

 
Discounted cash flows
 
Discount rate
 
21.6%
(13.6% - 56.5%)
 
Decrease
Level 3 Liabilities
 
 
 
 
 
 
 
 
 
 
Other liabilities—contingent consideration for THL Hotel Portfolio
 
8,903

 
Discounted cash flows
 
Discount rate
 
20.0%
 
Decrease
 
 
 
 
 
 
 
 
 
 
 
December 31, 2017
 
 
 
 
 
 
 
 
 
 
Level 3 Assets
 
 
 
 
 
 
 
 
 
 
Equity method investments—third party private equity funds
 
$
204,774

 
Discounted cash flows
 
Discount rate
 
14.6%
(11.0% - 20.0%)
 
Decrease
Equity method investments—other
 
26,408

 
Discounted cash flows
 
Discount rate
 
14.2%
(8.8% - 14.8%)
 
Decrease
Equity method investments—other
 
132,719

 
Transaction price(3)
 
Not applicable
 
Not applicable
 
Not applicable
N-Star CDO bonds
 
90,933

 
Discounted cash flows
 
Discount rate
 
24.0%
(10.8% - 87.4%)
 
Decrease
Level 3 Liabilities
 
 
 
 
 
 
 
 
 
 
Due to affiliates—contingent consideration for Internalization
 
20,650

 
Monte Carlo simulation
 
Benchmark FFO volatility
 
11.8%
 
Increase
 
 
 
 
 
 
Equity volatility
 
18.7%
 
Increase
 
 
 
 
 
 
Correlation (4)
 
80.0%
 
Increase
Other liabilities—contingent consideration for THL Hotel Portfolio
 
7,419

 
Discounted cash flows
 
Discount rate
 
20.0%
 
Decrease
__________
(1) 
Represents the directional change in fair value that would result from an increase to the corresponding unobservable input. A decrease to the unobservable input would have the reverse effect. Significant increases or decreases in these inputs in isolation could result in significantly higher or lower fair value measures.
(2) 
Fair value was estimated based on a combination of inputs, namely indicative prices of investments sold by the Company as well as underlying NAV of the respective funds on a quarter lag.
(3) 
Valued based upon transaction price of investments recently acquired or offer prices on investments pending sales.
(4) 
Represents assumed correlation between Benchmark FFO and the Company's class A common stock price.
The following table presents changes in recurring Level 3 fair value measurements, including realized and unrealized gains (losses) included in earnings and accumulated other comprehensive income.
 
 
Level 3 Assets
 
Level 3 Liabilities
(In thousands)
 
Loans Receivable
 
Equity Method Investments
 
Securities
 
Debt
 
Due to Affiliates—Contingent Consideration for Internalization
 
Other Liabilities—Contingent Consideration for THL Hotel Portfolio
Fair value at December 31, 2015
 
$

 
$

 
$

 
$

 
$
(52,990
)
 
$

Unrealized gain in earnings
 

 

 

 

 
11,740

 

Fair value at December 31, 2016
 
$

 
$

 
$

 
$

 
$
(41,250
)
 
$

Unrealized gain related to balance recorded in earnings
 
$

 
$

 
$

 
$

 
$
11,740

 
$

 
 
 
 
 
 
 
 
 
 
 
Fair value at December 31, 2016
 
$

 
$

 
$

 
$

 
$
(41,250
)
 
$

Acquired through the Merger
 

 
362,269

 
427,560

 

 

 

Consideration for business combination
 

 

 

 

 

 
(6,771
)
Consolidation of securitization trust
Consolidation of securitization trust
58,296

 

 

 
(56,928
)
 

 

Purchases, contributions or accretion
 

 
162,323

 
40,035

 
10,564

 

 

Paydowns or distributions
 
(10,564
)
 
(166,795
)
 
(120,728
)
 

 

 

Realized losses in earnings
 

 

 
(38,885
)
 

 

 

Unrealized gains:
 
 
 
 
 
 
 
 
 
 
 
 
In earnings
 
(2,309
)
 
6,104

 

 
1,822

 
20,600

 
(648
)
In other comprehensive income
 

 

 
15,261

 

 

 

Fair value at December 31, 2017
 
$
45,423

 
$
363,901

 
$
323,243

 
$
(44,542
)
 
$
(20,650
)
 
$
(7,419
)
Unrealized gains (losses) on ending balance:
 
 
 
 
 
 
 
 
 
 
 
 
In earnings
 
$
(2,309
)
 
$
6,104

 
$

 
$
1,822

 
$
20,600

 
$
(648
)
In other comprehensive income (loss)
 
$

 
$

 
$
15,261

 
$

 
$

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value at December 31, 2017
 
$
45,423

 
$
363,901

 
$
323,243

 
$
(44,542
)
 
$
(20,650
)
 
$
(7,419
)
Purchases, contributions or accretion
 

 
61,113

 
21,049

 

 

 

Paydowns, distributions or sales
 
(638
)
 
(188,409
)
 
(138,261
)
 
638

 

 

Deconsolidation
 
(44,070
)
 

 
(124,344
)
 
43,847

 

 

Transfer out of liabilities into equity
 

 

 

 

 
12,539

 

Transfers out of Level 3
 

 
(132,527
)
 

 

 
6,381

 

Contribution to Colony Credit (Note 4)
 

 
(26,134
)
 

 

 

 

Realized gains in earnings
 

 
3,208

 
3,877

 

 

 

Unrealized gains (losses):
 
 
 
 
 
 
 
 
 
 
 
 
In earnings
 
(715
)
 
(67
)
 

 
57

 
1,730

 
(1,484
)
In other comprehensive income (loss)
 

 

 
(21,437
)
 

 

 

Fair value at December 31, 2018
 
$

 
$
81,085

 
$
64,127


$

 
$


$
(8,903
)
Unrealized gains (losses) on ending balance:
 
 
 
 
 
 
 
 
 
 
 
 
In earnings
 
$
(715
)
 
$
(67
)
 
$

 
$
57

 
$
1,730

 
$
(1,484
)
In other comprehensive income (loss)
 
$

 
$

 
$
(3,386
)
 
$

 
$

 
$


Transfers of Level 3 Assets and Liabilities
Transfers of assets and liabilities into or out of Level 3 are presented at their fair values as measured at the end of the reporting period. Assets transferred out of Level 3 represent investments in third party private equity funds that were valued based on their contracted sales price in June 2018 and sold in September 2018. Liabilities transferred out of Level 3 represent dividends earned on the final number of shares of class A common stock and OP Units determined as of June 30, 2018, the end of the measurement period of the contingent consideration associated with the Internalization, and which were paid out in August 2018.
Investments Carried at Fair Value Using Net Asset Value
Investments in retail companies, which include a Company-sponsored non-traded REIT and a third party managed open-end mutual fund, as well as limited partnership interest in a third party private fund are valued using NAV of the respective vehicles effective January 1, 2018.
 
 
December 31, 2018
(In thousands)
 
Fair Value
 
Unfunded Commitments
Private fund—real estate
 
$
12,617

 
$
13,658

Retail Companies—real estate
 
21,674

 


The Company's limited partnership interest in the private fund is not subject to redemption, with distributions to be received through liquidation of underlying investments of the fund. The private fund has an expected life of eight years from its inception in 2017, which may be extended in one year increments up to two years at the discretion of its general partner, an equity method investee of the Company.
There are no restrictions on the Company's ability to redeem its investment in the third party managed open-end fund.
No secondary market currently exists for shares of the non-traded REIT and the Company does not currently expect to seek liquidity of its shares of the non-traded REIT. Subject to then-existing market conditions, the board of directors of the non-traded REIT, along with the Company, as sponsor, expects to consider alternatives for providing liquidity to the non-traded REIT shares beginning five years from completion of the offering stage in January 2016, but with no definitive date by which it must do so. In addition, the Company has agreed that any right to have its shares redeemed is subordinated to third party stockholders for so long as its advisory agreement is in effect. 
Nonrecurring Fair Values
The Company measures fair value of certain assets on a nonrecurring basis when events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Adjustments to fair value generally result from the application of lower of amortized cost or fair value accounting for assets held for sale or write-down of asset values due to impairment.
The following table summarizes assets carried at fair value on a nonrecurring basis, measured at the time of impairment.
 
 
December 31, 2018
 
December 31, 2017
(In thousands)
 
Level 2
 
Level 3
 
Total
 
Level 2
 
Level 3
 
Total
Real estate held for sale
 
$
68,864

 
$
200,281

 
$
269,145

 
$
13,252

 
$
36,246

 
$
49,498

Real estate held for investment
 

 
416,272

 
416,272

 

 
224,935

 
224,935

Intangible assets—investment management contracts
 

 
36,400

 
36,400

 

 
51,100

 
51,100

Equity method investments
 

 
32,761

 
32,761

 

 
11,871

 
11,871

The following table summarizes the fair value write-downs to assets carried at nonrecurring fair values during the periods presented.
 
 
Year Ended December 31,
(In thousands)
 
2018
 
2017
 
2016
Impairment loss
 
 
 
 
 
 
Real estate held for sale
 
$
77,211

 
$
25,619

 
$
11,334

Real estate held for investment
 
280,418

 
19,668

 
57

Intangible assets—lease intangibles
 
12,744

 

 

Intangible assets—investment management contracts
 
147,429

 
59,073

 
320

Intangible assets—customer relationships
 
10,109

 

 

Intangible assets—trade name
 
59,464

 

 

Equity method earnings
 
61,182

 
6,774

 

Impairment is discussed in Note 6 for loans receivable, Note 7 for equity method investments and Note 9 for goodwill and investment management intangible assets.
Real Estate Held For Sale—At December 31, 2018, real estate held for sale carried at fair value consisted primarily of properties in the European portfolio, valued using either broker price opinions, or a combination of market information, including third-party appraisals and indicative selling prices, adjusted as deemed appropriate by management to account for the inherent risk associated with the properties, and net of 5% selling cost, classified as Level 3.
Other significant real estate held for sale carried at fair value at December 31, 2018 comprised of certain hotels in the hospitality segment for which the Company previously held a long term hold strategy but in the third quarter of 2018, adopted a sales strategy. The majority of these hotels were classified as held for sale in the fourth quarter of 2018. Impairment was mostly recorded when the hotels were classified as held for investment, based on broker price opinions and net of 3% selling cost, classified as Level 3.
Additionally, real estate held for sale carried at fair value at December 31, 2018 include multi tenant office buildings and certain hotels in the THL Hotel Portfolio. These properties were valued based on either broker quotes, classified as Level 3, or auction prices or contracted sales prices, classified as Level 2, and in all cases, net of 1.5% or 2% selling costs.
At December 31, 2017, real estate held for sale carried at fair value were made up of properties in the healthcare and European portfolios as well as foreclosed properties.
Real Estate Held For Investment—At December 31, 2018, real estate held for investment carried at fair value consisted of $282.4 million of healthcare properties that were impaired in the fourth quarter of 2018, driven by shorter hold periods. In the fourth quarter of 2018, the Company reassessed the hold period on its healthcare properties, taking into consideration the Company's ability to refinance the related debt with upcoming maturities. The Company considered the possibility of shorter hold periods to be an indicator of impairment, among other factors. For properties for which indicators of impairment were identified, the Company compared their carrying values to the undiscounted future net cash flows expected to be generated by these properties over their hold periods, with terminal values estimated based on indicative capitalization rates, adjusted as appropriate for risk characteristics of each property. In performing this analysis, the Company considered the likelihood of possible outcomes under various hold period scenarios depending on its ability to refinance the related debt and applied a probability-weighted approach to different hold periods for each property. For properties where carrying value exceeded undiscounted future net cash flows, the carrying value was determined to not be recoverable. Fair values were estimated for these properties based on the income capitalization approach, using net operating income for each property and applying capitalization rates ranging from 5.5% to 11%. Impairment was measured as the excess of carrying value over fair value, totaling $212.0 million. As the impairment assessment involved subjectivity and judgment, actual results may differ if changes occur in the assumptions used and/or in market conditions and accordingly, negative changes to these variables would result in further impairment charge in the future.
Other significant real estate held for investment carried at fair value at December 31, 2018 pertained to certain healthcare properties and THL Hotel Portfolio that were damaged by hurricanes or fire in 2017, and further impaired in 2018, with impairment based on estimates from insurance appraisers.
At December 31, 2017, impaired real estate held for investment also included properties in the European portfolio which have mostly been transferred to held for sale or sold in 2018, as well as certain RIDEA properties that were converted into net lease properties in the healthcare segment.
Lease Intangible Assets—These represent lease intangibles that were evaluated and impaired in connection with the related healthcare properties that were impaired in the fourth quarter of 2018, consisting predominantly of above-market leases.

Fair Value Information on Financial Instruments Reported at Cost
Carrying amounts and estimated fair values of financial instruments reported at amortized cost are presented below. The carrying values of cash, interest receivable, accounts receivable, due from and to affiliates, interest payable and accounts payable approximate fair value due to their short term nature and credit risk, if any, are negligible.
 
 
Fair Value Measurements
 
Carrying Value
(In thousands)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
December 31, 2018
 
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
 
Loans at amortized cost
 
$

 
$

 
$
1,667,892

 
$
1,667,892

 
$
1,659,217

Liabilities
 
 
 
 
 
 
 
 
 
 
Debt at amortized cost
 
 
 
 
 
 
 
 
 
 
Convertible and exchangeable senior notes
 
547,300

 
13,095

 

 
560,395

 
612,150

Secured debt
 

 

 
9,218,692

 
9,218,692

 
9,228,721

Junior subordinated debt
 

 

 
169,619

 
169,619

 
199,086

December 31, 2017
 
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
 
Loans at amortized cost
 
$

 
$

 
$
3,232,301

 
$
3,232,301

 
$
3,178,339

Liabilities
 
 
 
 
 
 
 
 
 
 
Debt at amortized cost
 
 
 
 
 
 
 
 
 
 
Corporate credit facility
 

 
50,000

 

 
50,000

 
50,000

Convertible and exchangeable senior notes
 
608,491

 
13,979

 

 
622,470

 
610,331

Secured and unsecured debt
 

 

 
9,703,680

 
9,703,680

 
9,622,175

Securitization bonds payable
 

 
132,815

 
169,908

 
302,723

 
303,709

Junior subordinated debt
 

 

 
216,316

 
216,316

 
197,053


Loans Receivable—Loans receivable carried at amortized cost consist of first mortgages, subordinated mortgages and corporate loans, including such loans held by securitization trusts consolidated by the Company. Fair values were determined by comparing the current yield to the estimated yield of newly originated loans with similar credit risk or the market yield at which a third party might expect to purchase such investment; or based on discounted cash flow projections of principal and interest expected to be collected, which includes consideration of the financial standing of the borrower or sponsor as well as operating results of the underlying collateral. Carrying values of loans held for investment carried at amortized cost are presented net of allowance for loan losses, where applicable.
Debt—Fair value of convertible notes was determined using the last trade price in active markets. Fair value of exchangeable notes was determined based on unadjusted quoted prices in a non-active market. Fair values of the corporate credit facility and secured and unsecured debt were estimated by discounting expected future cash outlays at interest rates currently available to the Company for instruments with similar terms and remaining maturities; and such fair values approximated carrying value for floating rate debt with credit spreads that approximate market rates. Fair value of junior subordinated debt was based on unadjusted quotations from a third party valuation firm, with such quotes derived using a combination of internal valuation models, comparable trades in non-active markets and other market data. Fair value of securitization bonds payable was based on quotations from brokers or financial institutions that act as underwriters of the securitized bonds.
Other—The carrying values of cash, due from and to affiliates, other receivables and other payables approximate fair value due to their short term nature, and credit risk, if any, are negligible.